Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea · Delayed Price · Currency is KRW 5,210.00
-20.00 (-0.38%)
At close: May 29, 2026
Kyung Dong Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 11,633 | 8,529 | 5,470 | -20,708 | 12,161 | 12,672 |
Depreciation & Amortization | 3,832 | 3,678 | 5,420 | 5,849 | 6,704 | 7,011 |
Loss (Gain) From Sale of Assets | -2,280 | -2,094 | -92.39 | -61.03 | 142.27 | -73.22 |
Asset Writedown & Restructuring Costs | - | - | 197.41 | - | - | - |
Loss (Gain) From Sale of Investments | -1,698 | 748.83 | -1,765 | -2,149 | 1,709 | -786.97 |
Loss (Gain) on Equity Investments | -863.66 | 66.38 | -503.27 | -3,083 | -11,387 | 155.57 |
Provision & Write-off of Bad Debts | - | - | - | 1,577 | 64.7 | 66 |
Other Operating Activities | 3,056 | 2,476 | -6,917 | -236.45 | 4,218 | -2,090 |
Change in Accounts Receivable | -1,995 | 2,250 | -2,816 | 4,146 | -3,855 | -3,561 |
Change in Inventory | 5,334 | 172.68 | -7,837 | -4,494 | -2,619 | -636.73 |
Change in Accounts Payable | -1,840 | -344.59 | 123.61 | -776.13 | -92.64 | 1,873 |
Change in Other Net Operating Assets | 1,912 | 1,452 | 646.2 | 19,904 | -8,119 | -2,207 |
Operating Cash Flow | 17,090 | 16,934 | -8,074 | -31.94 | -1,075 | 12,422 |
Operating Cash Flow Growth | 32.78% | - | - | - | - | -27.42% |
Capital Expenditures | -17,143 | -18,394 | -7,618 | -6,290 | -10,574 | -3,926 |
Sale of Property, Plant & Equipment | 2,495 | 2,518 | 993.5 | 344.32 | 126.36 | 222.18 |
Sale (Purchase) of Intangibles | -1,622 | -1,968 | -3,792 | -1,677 | 161.82 | -811.28 |
Investment in Securities | 11,805 | 12,647 | 10,513 | 22,985 | -3,749 | 12,145 |
Other Investing Activities | 3,284 | 3,755 | 2,168 | 3,301 | 1,449 | 2,786 |
Investing Cash Flow | -1,182 | -1,143 | 2,264 | 18,664 | -12,585 | 10,713 |
Short-Term Debt Issued | - | 151,609 | 162,522 | 110,594 | 68,182 | - |
Long-Term Debt Issued | - | 18,400 | - | - | - | - |
Total Debt Issued | 127,429 | 170,009 | 162,522 | 110,594 | 68,182 | - |
Short-Term Debt Repaid | - | -160,250 | -138,897 | -119,663 | -44,251 | -481.93 |
Long-Term Debt Repaid | - | -79.52 | -148.88 | -573.83 | -1,595 | -1,534 |
Total Debt Repaid | -135,295 | -160,330 | -139,046 | -120,237 | -45,846 | -2,016 |
Net Debt Issued (Repaid) | -7,866 | 9,680 | 23,476 | -9,643 | 22,336 | -2,016 |
Repurchase of Common Stock | - | - | -1,280 | - | -750.51 | -5,517 |
Dividends Paid | -8,083 | -8,083 | -10,854 | -10,854 | -10,894 | -13,834 |
Other Financing Activities | -1,274 | -1,399 | -1,729 | -921.28 | -304.11 | -106.26 |
Financing Cash Flow | -17,222 | 198.62 | 9,613 | -21,418 | 10,388 | -21,474 |
Foreign Exchange Rate Adjustments | 75.29 | 49.97 | 186.58 | 11.75 | 17.78 | 153.47 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | 0 | - |
Net Cash Flow | -1,239 | 16,040 | 3,990 | -2,774 | -3,254 | 1,815 |
Free Cash Flow | -52.77 | -1,460 | -15,692 | -6,322 | -11,649 | 8,496 |
Free Cash Flow Margin | -0.03% | -0.74% | -8.09% | -3.89% | -6.38% | 4.78% |
Free Cash Flow Per Share | -1.93 | -53.82 | -582.38 | -232.98 | -428.12 | 308.70 |
Cash Interest Paid | 1,274 | 1,399 | 1,769 | 921.28 | 244.11 | 6.26 |
Cash Income Tax Paid | 858.19 | 387.8 | 4,777 | 2,796 | 5,692 | 8,698 |
Levered Free Cash Flow | -5,298 | -8,976 | -22,117 | 510.19 | -2,773 | 6,388 |
Unlevered Free Cash Flow | -4,179 | -7,867 | -20,767 | 1,508 | -2,231 | 6,429 |
Change in Working Capital | 3,412 | 3,530 | -9,883 | 18,780 | -14,686 | -4,532 |